Pfizer Inc.
http://www.pfizer.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Pfizer Inc.
Patent ‘March-In’ Policy Shift Will Likely Drive Uncertainty More Than Price Drops
Biden administration’s new framework will consider whether a product’s price is reasonable in deciding whether to exercise march-in rights. Numerous other factors could limit provision’s impact, but industry is concerned it will discourage firms from licensing government-funded inventions.
Finance Watch: Stark Contrast As Big FOPOs Reach Market, Other Firms Cut Costs
Public Company Edition: Arvinas grossed $350m in a private placement, while Xenon brought in $345m and Pharvaris raised $300m in follow-on public offerings. Fundraising remains challenging, however, so IGM Biosciences, Hansa Biopharma and other companies cut costs to save money.
Regeneron Releases New Linvoseltamab Analysis As It Inches Toward ASH, Regulatory Filing
The BCMAxCD3-directed bispecific for multiple myeloma is one of the crown jewels of Regeneron’s larger program to develop bispecifics as it diversifies beyond its traditional core franchises.
Biden's Latest Rx Pricing Moves Are At Once Bold And Incremental
As the president’s reelection campaign themes take shape, the administration is preparing to leverage NIH patents in ways it had previously eschewed. As with the merger oversight effort, though, the germs of the plans began earlier in Biden’s tenure.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Agouron Pharmaceuticals
- Alpharma Pharmaceuticals LLC
- American Home Products
- Amplyx Pharmaceuticals, Inc.
- Anacor Pharmaceuticals, Inc.
- Array BioPharma, Inc. (ARRY)
- Arixa Pharmaceuticals, Inc. Bamboo Therapeutics, Inc.
- Bioren, Inc,
- Coley Pharmaceutical Group, Inc.
- CovX Pharmaceuticals, Inc
- C.P. Pharmaceuticals International C.V.
- Encysive Pharmaceuticals
- Excaliard
- FoldRx Pharmaceuticals, Inc.
- Ferrosan Consumer Health
- GD Searle
- Hisun-Pfizer Pharmaceuticals Co., Ltd.
- Hospira, Inc.
- Icagen, Inc.
- Idun Pharmaceuticals, Inc.
- InnoPharma
- Javelin Pharmaceuticals, Inc.
- King Pharmaceuticals, Inc.
- Lederle Laboratories
- Mayne Pharma Limited
- Meridica Limited
- Neusentis
- Parke-Davis
- Pharmacia
- Pharmacia and Upjohn Co.
- PHT Pharma S.r.l.
- Powdermed
- Redvax GmbH
- ReViral Ltd.
- Serenex
- Strato Medical Corp.
- SUGEN
- Texas Biothechnology Corporation
- Thiakis Limited
- Vicuron Pharmaceuticals
- ViiV Healthcare
- Warner-Lambert
- Wyeth
- Wyeth-Ayerst Laboratories, Inc.
- Treerly Health Co., Ltd.
- Meridian Medical Technologies Inc.
- Montreal, Inc.
- Medivation, Inc.
- Sugen LLC
- Therachon Holding AG.
- Jones Pharma Inc.
- Trillium Therapeutics Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice